Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis
Abstract The availability of a simple, robust and non-invasive in vitro airway model would be useful to study the functionality of the cystic fibrosis transmembrane regulator (CFTR) protein and to personalize modulator therapy for cystic fibrosis (CF) patients. Our aim was to validate a CFTR functio...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ceebc254ff6749ddae89f16c9505710e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ceebc254ff6749ddae89f16c9505710e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ceebc254ff6749ddae89f16c9505710e2021-12-02T18:47:07ZValidation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis10.1038/s41598-021-94798-x2045-2322https://doaj.org/article/ceebc254ff6749ddae89f16c9505710e2021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94798-xhttps://doaj.org/toc/2045-2322Abstract The availability of a simple, robust and non-invasive in vitro airway model would be useful to study the functionality of the cystic fibrosis transmembrane regulator (CFTR) protein and to personalize modulator therapy for cystic fibrosis (CF) patients. Our aim was to validate a CFTR functional study using nasospheroids, a patient-derived nasal cell 3D-culture. We performed live-cell experiments in nasospheroids obtained from wild-type individuals and CF patients with different genotypes and phenotypes. We extended the existing method and expanded the analysis to upgrade measurements of CFTR activity using forskolin-induced shrinking. We also tested modulator drugs in CF samples. Immobilizing suspended-nasospheroids provided a high number of samples for live-cell imaging. The diversity observed in basal sizes of nasospheroids did not affect the functional analysis of CFTR. Statistical analysis with our method was simple, making this protocol easy to reproduce. Moreover, we implemented the measurement of inner fluid reservoir areas to further differentiate CFTR functionality. In summary, this rapid methodology is helpful to analyse response to modulators in CF samples to allow individualized treatment for CF patients.Maite CaluchoSilvia GartnerPaula BarrancoPaula Fernández-ÁlvarezRaquel García PérezEduardo F. TizzanoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Maite Calucho Silvia Gartner Paula Barranco Paula Fernández-Álvarez Raquel García Pérez Eduardo F. Tizzano Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis |
description |
Abstract The availability of a simple, robust and non-invasive in vitro airway model would be useful to study the functionality of the cystic fibrosis transmembrane regulator (CFTR) protein and to personalize modulator therapy for cystic fibrosis (CF) patients. Our aim was to validate a CFTR functional study using nasospheroids, a patient-derived nasal cell 3D-culture. We performed live-cell experiments in nasospheroids obtained from wild-type individuals and CF patients with different genotypes and phenotypes. We extended the existing method and expanded the analysis to upgrade measurements of CFTR activity using forskolin-induced shrinking. We also tested modulator drugs in CF samples. Immobilizing suspended-nasospheroids provided a high number of samples for live-cell imaging. The diversity observed in basal sizes of nasospheroids did not affect the functional analysis of CFTR. Statistical analysis with our method was simple, making this protocol easy to reproduce. Moreover, we implemented the measurement of inner fluid reservoir areas to further differentiate CFTR functionality. In summary, this rapid methodology is helpful to analyse response to modulators in CF samples to allow individualized treatment for CF patients. |
format |
article |
author |
Maite Calucho Silvia Gartner Paula Barranco Paula Fernández-Álvarez Raquel García Pérez Eduardo F. Tizzano |
author_facet |
Maite Calucho Silvia Gartner Paula Barranco Paula Fernández-Álvarez Raquel García Pérez Eduardo F. Tizzano |
author_sort |
Maite Calucho |
title |
Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis |
title_short |
Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis |
title_full |
Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis |
title_fullStr |
Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis |
title_full_unstemmed |
Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis |
title_sort |
validation of nasospheroids to assay cftr functionality and modulator responses in cystic fibrosis |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/ceebc254ff6749ddae89f16c9505710e |
work_keys_str_mv |
AT maitecalucho validationofnasospheroidstoassaycftrfunctionalityandmodulatorresponsesincysticfibrosis AT silviagartner validationofnasospheroidstoassaycftrfunctionalityandmodulatorresponsesincysticfibrosis AT paulabarranco validationofnasospheroidstoassaycftrfunctionalityandmodulatorresponsesincysticfibrosis AT paulafernandezalvarez validationofnasospheroidstoassaycftrfunctionalityandmodulatorresponsesincysticfibrosis AT raquelgarciaperez validationofnasospheroidstoassaycftrfunctionalityandmodulatorresponsesincysticfibrosis AT eduardoftizzano validationofnasospheroidstoassaycftrfunctionalityandmodulatorresponsesincysticfibrosis |
_version_ |
1718377707488673792 |